Biomerica Receives Authorization for Cancer and Chronic Disease Risk Detection Tests in Egypt.

Biomerica, a global provider of advanced diagnostic solutions, has received authorization from the Egyptian Drug Authority (EDA) to market and distribute its portfolio of rapid tests for cancer and chronic disease risk detection. The authorization covers tests for colorectal disease, breast self-exam, prostate disease, kidney disease, and H. pylori infection. The tests are designed for early detection of conditions related to common cancers and chronic diseases and are rapid, easy-to-use, and cost-effective for mass and individual use.